Surrogate Moms More Apt To Suffer Mental Illness
By Ernie Mundell HealthDay Reporter

TUESDAY, July 29, 2025 — Women who carry a baby for someone else — also known as gestational carriers or “surrogate moms” — may be at higher risk for mental illness during and after the pregnancy, new research shows.
“Our findings underscore the importance of adequate screening and counseling of potential gestational carriers before pregnancy about the possibility of a new-onset mental illness, or exacerbation of a prior mental-illness during or after pregnancy,” said lead author Dr. Maria Velez.
She's an adjunct scientist at the Institute for Clinical Evaluative Sciences (ICES) and associate professor of obstetrics and gynecology at McGill University in Montreal.
The findings were published July 25 in JAMA Network Open.
As the researchers explained, it’s long been known that “pregnancy is a period of increased vulnerability for psychological well-being."
However, “the mental health of gestational carriers is understudied,” they noted.
In the new report, Velez’ team tracked the mental health of new mothers involved in more than 767,400 births recorded in the Canadian province of Ontario between 2012 and 2021.
The vast majority (97.6%) of these pregnancies involved women who needed no assistance in conceiving or carrying a baby. However, 2.3% required help via in-vitro fertilization (IVF) and 0.1% involved surrogacy.
None of the women had any known history of mental health issues prior to their pregnancy. Their post-pregnancy mental health was tracked for a median of 4.5 years. (Median means half were tracked longer, half for a shorter time.)
Compared to women who carried their own baby, surrogate moms were more likely to have already given birth, and they were also more likely to live in a low-income area and have obesity and/or high blood pressure.
While the overall rate of new-onset mental health issues was low among the women, surrogate moms were 43% more likely to develop a mental illness for the first time compared to moms who conceived and carried their own baby, the research showed.
They were also 29% more prone to new-onset mental illness compared to women who’d used IVF to conceive.
Mental illnesses included in the study included anxiety disorders, psychosis, substance use disorder, any self-harm event or other mental illnesses.
Just how might the surrogacy process harm a woman’s mental health?
The authors cited several factors.
"Potential risk factors for new-onset mental illness among gestational carriers include the emotional effect of separation from the newborn, maintaining relationships with the intended parents and child, and societal scrutiny about their decision to pursue gestational carriage,” they wrote.
In Ontario, at least, people who are considering gestational carriage are typically screened for pre-existing mental illness.
However, the new findings “underscore the importance of counseling gestational carriers, who themselves have reported unanticipated health and/or mental health complications,” the researchers said.
For many women, postpartum mental health issues are often under-treated, the researchers added.
“Unfortunately, fewer than half of those who visit the emergency room for mental health concerns after childbirth receive timely follow-up care which leaves many, especially gestational carriers, at risk during a vulnerable period,” Velez said in a McGill news release.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-30 06:00
Read more

- Optical Coherence Tomography Feasible for Imaging Inner Ear
- Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvement
- Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease
- Living Near Polluted Missouri Creek as a Child Tied to Later Cancer Risk
- Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS G12D-mutated Locally Advanced or Metastatic Pancreatic Cancer
- Risk Has Doubled For Alcohol Liver Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions